Compare Axogen Inc (AXGN) vs NetEase Inc (NTES) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs NetEase Inc — how do they compare? Axogen Inc trades at $38.7 (market cap $2.06B), while NetEase Inc trades at $130.1 (market cap $82.39B). The key difference: NetEase Inc is far larger — about 40× Axogen Inc's market cap, and NetEase Inc pays a 2.35% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | NTES | |
|---|---|---|
Market Cap | $2.06B | $82.39B |
Sector | Technology | Media |
52-Week High | $46.19 | $159.34 |
52-Week Low | $11.28 | $109.26 |
Enterprise Value | $1.98B | $58.86B |
Dividend Yield | — | 2.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
NTES trades at $131.43, up 2.66% today, with a bullish technical signal and strong fundamentals. The stock shows robust profitability with a 29.84% net income margin and 22.12% ROE. Recent Q1 2026 earnings beat expectations at $2.53 EPS versus $2.19 forecast. Analyst sentiment is overwhelmingly positive with 82% buy ratings. Cash flow from operations surged to $50.74B in 2025, though net cash flow was negative due to heavy investing activities.
Outlook remains favorable given earnings momentum, international expansion in gaming, and attractive valuation at 16.89 P/E. Risks include reliance on Chinese market and competitive pressures. Wall Street sees 34.7% upside potential based on price targets, supporting a constructive view for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →
